PlainPharmaWatch

CMS Open Payments · Program Year 2024

Aytu BioPharma, Inc.

Aytu BioPharma, Inc. reported $14,745.49 in payments to 873 physicians and teaching hospitals across 873 transactions.

See the rankings → How this is sourced
$14.7K
Total payments
873
Transactions
873
Recipients
+$3.8K
General Payments vs PY2023

Aytu BioPharma, Inc. reported $14,745.49 in payments to 873 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1579 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $16.89 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Aytu BioPharma, Inc. pairs modest payment volume with an unusually diversified payment pattern across a wide recipient base.

#1579
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Aytu BioPharma, Inc.'s CMS-reported General Payments increased by $3.8K (+34.5%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: AYTU BIOPHARMA, INC.PY2023: AYTU BIOPHARMA, INC.PY2024: Aytu BioPharma, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$11.0KPY2024$14.7K
PY2023
$10,959.15
PY2024
$14,745.49

How Aytu BioPharma, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Aytu BioPharma, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$14,745 18th percentile higher than 18% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). This entry sits in this band. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Aytu BioPharma, Inc.

Averaging $16.89 per transaction and $16.89 per recipient, Aytu BioPharma, Inc.'s Program Year 2024 total comes to $14,745.49 across 873 transactions and 873 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1579 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $14.7K (100.0% of the company's reported total, 873 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Aytu BioPharma, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $14.7K, 100.0% of the company's reported total.

How Aytu BioPharma, Inc. divides its payments

How the reported total splits across payment categories

1. Food and Beverage$14.7K
Payment Type Amount Transactions
Food and Beverage $14.7K 873

Recipient Concentration in General Payments

The five largest recipient relationships account for $363.65 (2.5%) of $14,745.49 in this company's General Payments records across 718 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Aytu BioPharma, Inc.

The five named recipients with the highest reported General Payments from this company

Jennifer Caicedo$79.84Hannah Mules$70.96Cathy Gvozden$70.95Andre Gvozden$70.95Eliza Huebner$70.95
  1. 1

    Jennifer Caicedo

    $79.84 across 4 reported transactions

  2. 2

    Hannah Mules

    $70.96 across 4 reported transactions

  3. 3

    Cathy Gvozden

    $70.95 across 4 reported transactions

  4. 4

    Andre Gvozden

    $70.95 across 4 reported transactions

  5. 5

    Eliza Huebner

    $70.95 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $16.89. Average per recipient: $16.89.

Total Amount

$14,745.49

Avg per Transaction

$16.89

Avg per Recipient

$16.89

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Aytu BioPharma, Inc. Share

0.0%

#1579 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Aytu BioPharma, Inc.

Medela AG

$14.7K 20 recipients

Celltrion Healthcare Canada Ltd.

$14.7K 6 recipients

Kub Technologies Inc.

$14.7K 131 recipients

Les Laboratoires Servier

$14.8K 5 recipients

Retropsoas Technologies, LLC

$14.6K 12 recipients

North American Rescue, LLC

$14.6K 8 recipients

Frequently Asked Questions

How much did Aytu BioPharma, Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Aytu BioPharma, Inc., totaling $14,745.49 across 873 transactions to physicians and hospitals.
How many physicians received payments from Aytu BioPharma, Inc.? ▾
873 physicians and teaching hospitals received payments from Aytu BioPharma, Inc. in 2024, averaging $16.89 per recipient.
What types of payments did Aytu BioPharma, Inc. make? ▾
General payments from Aytu BioPharma, Inc. span 1 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $14.7K, representing 100.0% of the company's reported total.
How does Aytu BioPharma, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Aytu BioPharma, Inc. ranks #1579 by total payment amount.
What is the average payment size from Aytu BioPharma, Inc.? ▾
The average transaction from Aytu BioPharma, Inc. was $16.89 in 2024. The company made 873 total transactions to 873 recipients.
Where does the payment data for Aytu BioPharma, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Aytu BioPharma, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.